Parallel Advisors, LLC Corcept Therapeutics Inc Transaction History
Parallel Advisors, LLC
- $3.67 Billion
- Q1 2024
A detailed history of Parallel Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,815,677 shares of CORT stock, worth $115 Million. This represents 2.62% of its overall portfolio holdings.
Number of Shares
3,815,677
Previous 3,768,245
1.26%
Holding current value
$115 Million
Previous $122 Million
21.47%
% of portfolio
2.62%
Previous 3.65%
Shares
22 transactions
Others Institutions Holding CORT
# of Institutions
314Shares Held
93.8MCall Options Held
2.02MPut Options Held
3.24M-
Black Rock Inc. New York, NY16.8MShares$508 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.57MShares$289 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY8.3MShares$251 Million9.24% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.12MShares$215 Million0.28% of portfolio
-
State Street Corp Boston, MA3.58MShares$108 Million0.0% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $3.23B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...